Philip Jones, Ph.D., is a drug hunter that leads a multi-disciplinary team of scientists whose mission is to identify the next generation of cancer medicines, move those into clinical trials and hopefully into clinical practice. Developing medicines is a challenging process, and engineering all the necessary properties for a single molecule to be effective in patients requires collaboration and team work across many disciplines. Jones is fortunate to work with a high-performance team, who has already delivered a drug into trials at MD Anderson since its inception. His team also has a number of promising programs coming along behind.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
John S. Dunn Gulf Coast Consortium for Chemical Genomics
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.